Oramed To Present At Oppenheimer Annual Israeli Conference

JERUSALEM, May 16, 2016 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming Oppenheimer Annual Israeli Conference, taking place on May 22, 2016 in Tel Aviv. Nadav Kidron, CEO of Oramed, will present a corporate overview at the conference.

Back to news